Annals of Behavioral Medicine

, Volume 23, Issue 4, pp 304–312 | Cite as

The relation between beliefs about drug treatments for HIV and sexual risk behavior in gay and bisexual men



This study examined the relation between gay and bisexual men’s (N = 575) beliefs about highly active antiretroviral therapy (HAART) and other HIV-related beliefs, intentions, and risk behaviors. Confirmatory factor analysis verified three belief factors: the extent to which HAART improves health among HIV-infected individuals, decreases the risk of HIV transmission, and is complicated and of limited efficacy. Men who endorsed the belief that HAART decreases HIV transmission risk expressed lower intentions to use condoms for anal sex and were more likely to have engaged in unprotected anal intercourse with a casual partner. HIV-negative men who believed that HAART decreases transmission risk also perceived themselves to be more susceptible to HIV infection. Statistical evidence indicated that perceptions of susceptibility partially mediate the relation between sexual risk behavior and beliefs about HAART, suggesting that beliefs may result from, rather than cause, increased risk behavior.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. (1).
    Shindle K: Barebacking? Brainless.The Advocate. 1998,Feb 8:9.Google Scholar
  2. (2).
    Signorile M: Bareback and restless.Out. 1997,July:36–37.Google Scholar
  3. (3).
    Collier AC, Coombs RW, Schoenfeld DA, et al.: Treatment of human immunodeficiency virus infection with sasquinavir, zidovudine, and zalcitabine.New England Journal of Medicine. 1996,334:1011–1017.PubMedCrossRefGoogle Scholar
  4. (4).
    Deeks SG, Smith M, Holodniy M, Kahn JO: HIV-1 protease in-hibitors: A review for clinicians.Journal of the American Medical Association. 1997,276:146–154.Google Scholar
  5. (5).
    McDonald CK, Kuritzkes DR: Human immunodeficiency virus type 1 protease inhibitors.Archives of Internal Medicine. 1997,157:951–959.PubMedCrossRefGoogle Scholar
  6. (6).
    Anderson DJ, O’Brien TR, Politch JA, et al.: Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen.Journal of the American Medical Association. 1992,267:2769–2774.PubMedCrossRefGoogle Scholar
  7. (7).
    Dornadula G, Zhang H, VanUitert B, et al.: Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.Journal of the American Medical Association. 1999,282:1627–1632.PubMedCrossRefGoogle Scholar
  8. (8).
    Rasheed S, Li Z, Xu D, Kovacs A: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.American Journal of Obstetrics and Gynecology. 1996,175:122–130.PubMedCrossRefGoogle Scholar
  9. (9).
    Royce RA, Sena A, Cates W, Cohen MS: Sexual transmission of HIV.New England Journal of Medicine. 1997,336:1072–1078.PubMedCrossRefGoogle Scholar
  10. (10).
    Vernazza PL, Gilliam BL, Dyer J, et al.: Quantification of HIV in semen: Correlation with antiviral treatment and immune status.AIDS. 1997,11:987–993.PubMedCrossRefGoogle Scholar
  11. (11).
    Cardo DM, Culver DH, Ciesielski CA, et al.: A case-control study of HIV seroconversion in health care workers after percutaneous exposure.New England Journal of Medicine. 1997,337:1485–1490.PubMedCrossRefGoogle Scholar
  12. (12).
    Katz M, Gerberding JL: Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.New England Journal of Medicine. 1997,336:1097–1100.PubMedCrossRefGoogle Scholar
  13. (13).
    Carpenter CC, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society-USA Panel.Journal of the American Medical Association. 1997,277:1962–1969.PubMedCrossRefGoogle Scholar
  14. (14).
    Haubrich RH, Little SJ, Currier JS, et al.: The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response.AIDS. 1999,13:1099–1107.PubMedCrossRefGoogle Scholar
  15. (15).
    Lucas GM, Chaisson RE, Moore RD: Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.Annals of Internal Medicine. 1999,131:81–87.PubMedGoogle Scholar
  16. (16).
    Becker MH: The health belief model and personal health behavior.Health Education Monographs. 1974,2:324–508.Google Scholar
  17. (17).
    Rogers RW: A protection motivation theory of fear appeals and attitude change.Journal of Psychology. 1975,91:93–114.Google Scholar
  18. (18).
    Weinstein ND: The precaution adoption process.Health Psychology. 1988, 7:355–386.PubMedCrossRefGoogle Scholar
  19. (19).
    Catania JA, Kegeles SM, Coates TJ: Towards an understanding of risk behavior: An AIDS risk reduction model (ARRM).Health Education Quarterly. 1990,17:53–72.PubMedGoogle Scholar
  20. (20).
    Fisher JD, Fisher WA: Changing AIDS-risk behavior.Psychological Bulletin. 1992,111:455–474.PubMedCrossRefGoogle Scholar
  21. (21).
    Dilley JW, Woods WJ, McFarland W: Are advances in treat-ment changing views about high-risk sex?New England Journal of Medicine. 1997,337:501–502.PubMedCrossRefGoogle Scholar
  22. (22).
    Kelly JA, Hoffmann RG, Rompa D, Gray M: Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex.AIDS. 1998,12:F91-F95.PubMedCrossRefGoogle Scholar
  23. (23).
    Vanable PA, Ostrow DG, McKirnan DJ, Taywaditep KJ, Hope B: Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men.Health Psychology. 2000, 19:134–145.PubMedCrossRefGoogle Scholar
  24. (24).
    Van de Ven P, Crawford J, Kippax S, Knox S, Prestage G: A scale of optimism-scepticism in the context of HIV treatments.AIDS-Care. 2000,12:171–176.PubMedCrossRefGoogle Scholar
  25. (25).
    Perloff RM: Defining and measuring attitude.The Dynamics of Persuasion. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc., 1993, 25–49.Google Scholar
  26. (26).
    Ajzen I, Fishbein M:Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice Hall, 1980.Google Scholar
  27. (27).
    Ajzen I, Madden TJ: Prediction of goal-directed behavior: Attitudes, intentions, and perceived behavioral control.Journal of Experimental Social Psychology. 1986,22:453–474.CrossRefGoogle Scholar
  28. (28).
    Fishbein M, Ajzen I:Belief, Attitude, Intention, and Behavior: An Introduction to Theory and Research. Reading, MA: Addison-Wesley, 1975.Google Scholar
  29. (29).
    Kalichman SC, Nachimson D, Cherry C, Williams E: AIDS treatment advances and behavioral prevention setbacks: Preliminary assessment of reduced perceived threat of HIV-AIDS.Health Psychology. 1998,17:546–550.PubMedCrossRefGoogle Scholar
  30. (30).
    Joseph JG, Montgomery SB, Emmons C, et al.: Perceived risk of AIDS: Assessing the behavioral and psychological consequences in a cohort of gay men.Journal of Applied Social Psychology. 1987, 17:231–250.CrossRefGoogle Scholar
  31. (31).
    Emmons C, Joseph JG, Kessler RC, et al.: Psychosocial predictors of reported behavior change in homosexual men at risk for AIDS.Health Education Quarterly. 1986,13:331–345.PubMedGoogle Scholar
  32. (32).
    Aspinwall LG, Kemeny ME, Taylor SE, Schneider SG, Dudley JP: Psychosocial predictors of gay men’s AIDS risk-reduction behavior.Health Psychology. 1991,10:432–444.PubMedCrossRefGoogle Scholar
  33. (33).
    Bryan AD, Aiken LS, West SG: Young women’s condom use: The influence of acceptance of sexuality, control over the sexual encounter, and perceived susceptibility to common STDs.Health Psychology. 1997,16:468–479.PubMedCrossRefGoogle Scholar
  34. (34).
    Gerrard M, Gibbons FX, Bushman BJ: Relation between perceived vulnerability to HIV and precautionary sexual behavior. Psychological Bulletin. 1996,19:390–409.CrossRefGoogle Scholar
  35. (35).
    Kowalewski MR, Henson KD, Longshore D: Rethinking perceived risk and health behavior: A critical review of HIV prevention research.Health Education & Behavior. 1997,24:313–325.CrossRefGoogle Scholar
  36. (36).
    Sanderson CA, Jemmott JB: Moderation and mediation of HIV-prevention interventions: Relationship status, intentions and condom use among college students.Journal of Applied Social Psychology. 1996,26:2076–2099.CrossRefGoogle Scholar
  37. (37).
    Morrison DM, Rogers Gillmore M, Baker SA: Determinants of condom use among high-risk adults: A test of the theory of reasoned action.Journal of Applied Social Psychology. 1995,25:651–676.CrossRefGoogle Scholar
  38. (38).
    de Wit JBF, van Griensven GJP, Kok G, Sandfort TGM: Why do homosexual men relapse into unsafe sex? Predictors of resumption of unprotected anogenital intercourse with casual partners.AIDS. 1993,7:1113–1118.PubMedCrossRefGoogle Scholar
  39. (39).
    Sheeran P, Orbell S: Do intentions predict condom use? Meta-analysis and examination of six moderator variables.British Journal of Social Psychology. 1998,37:231–250.PubMedGoogle Scholar
  40. (40).
    Kauth MR, St. Lawrence JS, Kelly JA: Reliability of retrospective assessments of sexual HIV risk behavior: A comparison of biweekly, 3-month, and 12-month self-reports.AIDS Education and Prevention. 1991,3:207–214.PubMedGoogle Scholar
  41. (41).
    Bentler PM:EQS for Unix. Version 5.1. [Computer software]. Encino, CA: Mulitvariate Software, Inc., 1995.Google Scholar
  42. (42).
    Aiken LS, West SG:Multiple Regression: Testing and Interpreting Interactions. Newbury Park, CA: Sage, 1991.Google Scholar
  43. (43).
    Hosmer DW, Lemeshow S:Applied Logistic Regression. New York: Wiley, 1989.Google Scholar
  44. (44).
    Bentler PM: Comparative fit indices in structural models.Psychological Bulletin. 1990,107:238–246.PubMedCrossRefGoogle Scholar
  45. (45).
    Steiger JH: Some additional thoughts on components, factors, and factor indeterminancy.Multivariate Behavioral Research. 1990,25:41–45.CrossRefGoogle Scholar
  46. (46).
    Barron RM, Kenny DA: The moderator-mediator distinction in social psychological research: Conceptual, strategic, and statistical considerations.Journal of Personality and Social Psychology. 1986,51:1173–1182.CrossRefGoogle Scholar
  47. (47).
    Sobel ME: Asymptotic confidence intervals for indirect effects in structural equations.Sociological Methodology. 1982,12:290–312.CrossRefGoogle Scholar
  48. (48).
    Elford J, Bolding G, Maguire M, Sherr L: Combination therapies for HIV and sexual risk behavior among gay men.Journal of Acquired Immunodeficiency Syndrome. 2000,23:266–271.Google Scholar
  49. (49).
    Remien RH, Wagner G, Carballo-Diéguez A, Dolezal C: Who may be engaging in high-risk sex due to medical treatment advances?AIDS. 1998,12:1560–1561.PubMedCrossRefGoogle Scholar
  50. (50).
    Siegel K, Mesagno FP, Chen JY, Christ G: Factors distinguishing homosexual males practicing risky and safer sex.Social Science and Medicine. 1989,28:561–569.PubMedCrossRefGoogle Scholar
  51. (51).
    Hays RB, Kegeles SM, Coates TJ: High HIV risk-taking among young gay men.AIDS. 1990,4:901–907.PubMedCrossRefGoogle Scholar
  52. (52).
    Kelly JA, St. Lawrence JS, Hood HV, Brasfield TL: Behavioral intervention to reduce AIDS risk activities.Journal of Consulting and Clinical Psychology. 1989,57:60–67.PubMedCrossRefGoogle Scholar
  53. (53).
    Cohen J, Cohen P:Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences (2nd Ed.). Hillsdale, NJ: Lawrence Erlbaum Associates, Inc., 1983.Google Scholar

Copyright information

© The Society of Behavioral Medicine 2001

Authors and Affiliations

  1. 1.Department of PsychologyArizona State UniversityTempe

Personalised recommendations